CLINICAL / ANATOMIC PATHOLOGY / CRO LABORATORIES
Current Listings
Under LOI: Tech-2538: Fairly New, Profitable Clinical Lab in Georgia
This Lab offers a solid platform for growth. A completely managed Lab needs very little owner involvement. Revenue $300K; Discretionary Earnings $110K.
UNDER LOI: Tech-2532: Clinical Research Organization (CRO) – Niche Expertise and Strong Growth
This CRO has niche expertise in long-term care facilities and with elderly populations. Strong growth in recent years. Revenue: $6.9M; EBITDA: $2.6M; Asking Price: $12M.
Tech-2524: Brand New Molecular CLIA Lab in the TN
Validated for Molecular Detection of Pathogens and Covid-19. Debt-free. Can optionally provide customization and complete management. $550K Asking Price.
UNDER LOI: Tech-2503: Very Profitable, Well-Established Clinical Lab in the South East
The lab has a diversified Revenue Stream from Toxicology, Women’s Health, UTI, Covid, and Respiratory Panel Testing. The lab is well-positioned to continue to grow post-Covid. Projected 2021 Revenue: $6M, EBITDA: $2M.
SOLD: Tech-2506: CRO in South East with Expertise in NGS, RNA, Genomics, Biomarker Services
SOLD: The CRO Lab is one of the Early Adapters in Next Generation Sequences and deep expertise in research and applications Biomarkers, Disease Diagnostics and Treatment Development, using RNA, mRNA and microRNA arrays.
Sold Clinical and Pathology Labs
SOLD: Tech-2534: Profitable NJ Lab with NY, NJ and PA Licenses
This turn-key lab comes with a great location, excellent growth potential with marketing, and hard-to-get licenses of NY, NJ, and PA in favorable MAC. Had Medicare, Medicaid, and Multiplan. Price $2.2 million
UNDER LOI: Tech-2532: Clinical Research Organization (CRO) – Niche Expertise and Strong Growth
This CRO has niche expertise in long-term care facilities and with elderly populations. Strong growth in recent years. Revenue: $6.9M; EBITDA: $2.6M; Asking Price: $12M.
SOLD: Tech-2506: CRO in South East with Expertise in NGS, RNA, Genomics, Biomarker Services
SOLD: The CRO Lab is one of the Early Adapters in Next Generation Sequences and deep expertise in research and applications Biomarkers, Disease Diagnostics and Treatment Development, using RNA, mRNA and microRNA arrays.
SOLD: Tech-2440: Anatomic Pathology Lab in the North East
Very profitable, successful, and fast-growing anatomical lab in the North East. Known for its high level of service. Revenue; $4-5MM; EBITDA: $1.5-$2MM
SOLD: Tech-2466: Profitable Clinical Lab in Mountain States
SOLD: Profitable Clinical Lab in the Mountain States. Has important network contracts. Gross Revenue: $480K; SDE: $180K; Asking Price: $900K. Includes Aetna, BC, Cigna, Medicare.
SOLD – Tech-2472: NY / CLIA License of a Clinical Lab
SOLD: NY CLIA license. This Clinical lab does Endocrinology / Fertility testing and comes with clean CLIA and NY state licenses. The corporation is only two years old.
SOLD: Tech-2461: Turn-key, High-Capacity, Clinical and Toxicology Labs with two Clean CLIAs in Texas
A rare opportunity to acquire two adjacent CLIA labs - Both Labs have Licenses for 38 states. Comes with completely paid off newer equipment which were bought for $2.7M. Asking price $1.1M. Includes,...
SOLD: Tech-2243: DNA Paternity Testing, Forensic Testing Lab in South East
SOLD Tech-2243: DNA Paternity Testing, Forensic Testing Lab in South East. Gross Income (2012): $288K, Discretionary Cash Flow: $134K, assets: $125K.
SOLD: Tech-1510: Clinical Diagnostic Lab in Central Philadelphia
SOLD Tech-1510: Clinical Diagnostic Lab in Central Philadelphia. One Year Old, CLIA-Approved, Ideal Turn-key Business Opportunity for a Large Physician’s Group. Potential Annual Revenue and Net Profit: $3M and $1M.